Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).

  • Authors:
    • M Resnicoff
  • View Affiliations

  • Published online on: May 1, 1998     https://doi.org/10.3892/ijmm.1.5.883
  • Pages: 883-891
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Antisense-mediated downregulation of the insulin-like growth factor I receptor results in massive apoptosis of tumor cells in vivo, leading to abrogation of tumorigenesis. In addition to the apoptotic effect, antitumor responses are elicited in syngeneic immunocompetent animals, protecting them from subsequent tumor challenge and causing regression of established tumors with no further recurrence. The mechanisms involved in the antitumor responses elicited in the animals following exposure to antisense cells are discussed, focusing on the immunogenicity of the antisense cells as well as the effectors that participate in these responses.

Related Articles

Journal Cover

May 1998
Volume 1 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Resnicoff M: Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).. Int J Mol Med 1: 883-891, 1998
APA
Resnicoff, M. (1998). Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).. International Journal of Molecular Medicine, 1, 883-891. https://doi.org/10.3892/ijmm.1.5.883
MLA
Resnicoff, M."Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).". International Journal of Molecular Medicine 1.5 (1998): 883-891.
Chicago
Resnicoff, M."Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).". International Journal of Molecular Medicine 1, no. 5 (1998): 883-891. https://doi.org/10.3892/ijmm.1.5.883